Aimco Pesticides Limited has entered into a Student Research Project Agreement with the University of Melbourne and Aimco International FZE to conduct studies on novel products for agriculture. The agreement, dated June 19, 2026, involves the company facilitating a payment of AUD $191,096.40 (inc. GST) to the University of Melbourne through its wholly owned subsidiary. This strategic partnership is intended to advance research in the agricultural sector.

The disclosures were made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Aimco International FZE is a wholly owned subsidiary of Aimco Pesticides Limited, holding 100% shareholding. The University of Melbourne holds no shareholding in the listed entity.

The transaction has been classified as a related party transaction and was conducted at arm's length. The agreement imposes a financial liability of AUD $191,096.40 (inc. GST) on the company. There is no impact on the management or control of Aimco Pesticides Limited as a result of this agreement.

Key Agreement Details

Aimco Pesticides Limited reported a widened consolidated net loss of ₹1,219.68 lakh for the financial year ended March 31, 2026, compared to a net loss of ₹724.34 lakh in the previous year. Revenue from operations fell to ₹15,388.27 lakh from ₹19,765.89 lakh in FY25, reflecting a decline in operational performance. The company’s Board of Directors approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, during a meeting held on May 28, 2026.

The statutory auditors, M/s. CNK & Associates LLP, issued an audit report with an unmodified opinion on the financial results. For the standalone entity, the net loss for FY26 was ₹1,179.73 lakh, widening from ₹738.57 lakh in FY25. Total income for the year stood at ₹15,492.80 lakh, down from ₹19,850.85 lakh in the prior year. The company operates in a single primary segment, Agrochemicals.

Financial Performance

The financial results indicate a challenging year with increased expenses and reduced income. Total expenses for the consolidated entity rose to ₹17,127.84 lakh in FY26 from ₹16,569.20 lakh in the previous year. Finance costs and depreciation expenses contributed to the pressure on profitability.

Operational Highlights

The company’s earnings per share (EPS) for the consolidated entity worsened to a loss of ₹12.47 in FY26 from a loss of ₹7.55 in the previous year. Basic and diluted EPS for the standalone entity were reported at a loss of ₹12.06 for FY26. The board also approved the re-appointment of M/s. V. J. Talati & Co., Cost Accountants, as the Cost Auditor for the financial year 2026-27.

Assets and Liabilities

As of March 31, 2026, the company’s total consolidated assets stood at ₹12,959.44 lakh, a decrease from ₹17,601.98 lakh in the previous year. Current assets declined significantly to ₹8,913.83 lakh from ₹13,670.64 lakh, driven by reductions in inventories and trade receivables. Total equity and liabilities were reported at ₹12,959.44 lakh.